A 12-week comparison of bimatoprost 0.03% and a fixed combination of latanoprost 0.005% and timolol 0.5% in reducing the 24-hour IOP in glaucoma patients. A European multi-centre, randomised, double-masked trial

L.M. Rossetti
European Glaucoma Panel

Publication date

May 2006

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Abstract

Purpose: To compare the 24\u2013h mean IOP between bimatoprost and the fixed combination of latanoprost and timolol when switched from a non\u2013fixed combination of latanoprost and timolol. Methods: This randomised, double masked trial was carried out in 7 centres throughout Europe. Included were patients who were controlled (IOP <22 mmHg) on the unfixed combination of latanoprost and timolol for at least 3 months prior to the baseline visit or patients on monotherapy either with latanoprost or timolol who were eligible for dual therapy being uncontrolled. The last group of patients underwent a 6 weeks wash\u2013in phase with the non\u2013fixed combination of latanoprost and timolol before baseline IOP determination and inclusion into the...

Extracted data

We use cookies to provide a better user experience.

Data Protection

A 12-week comparison of bimatoprost 0.03% and a fixed combination of latanoprost 0.005% and timolol 0.5% in reducing the 24-hour IOP in glaucoma patients. A European multi-centre, randomised, double-masked trial

Abstract

Extracted data

A 12-week comparison of bimatoprost 0.03% and a fixed combination of latanoprost 0.005% and timolol 0.5% in reducing the 24-hour IOP in glaucoma patients. A European multi-centre, randomised, double-masked trial

Abstract

Extracted data

Related items

Related items